Skip to main content

Preliminary Research Findings for Cannabinoids

Aug 25th 2020

While there isn't enough clinical trial data to support sound conclusions on the effectiveness of CBD for different human applications, we have learned a lot from cell culture and animal model experiments.

Cells and animals share most of the same biochemical functions as humans, so we can learn how CBD might be working on our own biochemistry. This data cannot be taken as a health claim, and even clinical trials can only make conclusions limited to the specific product studied and the population of subjects that were included in the trial.

However, we believe it is important for users to understand how natural compounds interact with biological pathways, so we have compiled a list of studies looking at the effects of CBD on different targets of clinical interest*. Some of these targets are implicated in addiction, alzheimer's, anxiety, arthritis, brain damage, cancer, cardiac disease, depression, diabetes, epilepsy, inflammation, kidney disease, liver disease, multiple sclerosis, nausea, osteoporosis, and parkinson's disease*.

*These statements and any associated products have not been evaluated by the food and drug administration and are not intended to diagnose, treat, cure or prevent any disease.